

The team at Morgans has been running the rule over a number of ASX 200 shares once again.
Among its best ideas for April are the shares listed below. Here’s why they broker rates these ASX 200 shares highly:
QBE Insurance Group Ltd (ASX: QBE)
Morgans is feeling bullish about this insurance giant’s shares and believes they could be in the buy zone. This is due to premium increases, its positive cost cutting outlook, and attractive valuation. The broker currently has an add rating and $13.50 price target on its shares.
It said: “With strong rate increases still flowing through QBE’s insurance book, and further cost-out benefits to come, we expect QBE’s earnings profile to improve strongly over the next few years. The stock also has a robust balance sheet and remains relatively inexpensive overall trading on ~14x FY22F PE.”
ResMed Inc (ASX: RMD)
Another ASX 200 share that Morgans has on its best ideas listed is ResMed. The broker is very positive on the sleep treatment focused medical device company due to its long term growth outlook. Morgans has an add rating and $40.46 price target on the company’s shares.
Its analysts commented: “While we believe the next few quarters will likely be volatile, as Covid-related demand for ventilators continues to slow and core sleep apnoea volumes gradually lift, nothing changes our medium/longer term view that the company remains well-placed as it builds a unique, patient-centric, connected-care digital platform that addresses the main pinch points across the healthcare value chain.”
Seek Limited (ASX: SEK)
A final ASX 200 share on the broker’s best ideas list is Seek. Although Morgans only has a hold rating, its price target of $32.33 offers enough potential upside to warrant its inclusion. The broker feels Seek is well-placed to benefit from strong ad volumes.
Morgans said: “Of the classifieds players, we continue to see SEK as the one with the most relative upside, a view that’s based on the sustained listings growth we’ve seen over the period. The tailwinds that have driven elevated job ads (~250k currently, +35% on pcp) and updated guidance (FY22 EBITDA updated ~16% at the midpoint to A$490m-A$515m) appear to still remain in place, i.e. subdued migration, candidate scarcity and the drive for greater employee flexibility.”
The post Broker names 3 of the best ASX 200 shares to buy in April appeared first on The Motley Fool Australia.
Wondering where you should invest $1,000 right now?
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.
*Returns as of January 12th 2022
More reading
- Analysts name 3 ASX 200 shares that could generate strong returns
- Worried about how the federal budget might impact your ASX shares? Here’s what Goldman says
- 3 ASX shares primed to bounce back: expert
- Growth will be back! Expert picks 7 ASX shares to buy now
- Broker names 2 ASX 200 shares to buy with almost 20% upside
Motley Fool contributor James Mickleboro owns SEEK Limited. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended ResMed. The Motley Fool Australia has recommended ResMed Inc. and SEEK Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.
from The Motley Fool Australia https://ift.tt/k2DvPzX











